FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097320744> ?p ?o ?g. }

• W3097320744 abstract "Objective: Patients with myeloproliferative neoplasms (MPN) are at an increased risk of developing thrombosis which leads to significant levels of morbidity and mortality. Although this propensity for thrombosis has been attributed to increased blood counts, other factors such as endothelial cell (EC) dysfunction likely play an important role. Previous studies have provided evidence of EC involvement by JAK2V617F which is known to be present in blood cells of 50-95% of patients with MPN. Furthermore, the morphological and functional changes of this mutation, a single nucleotide mutation in the cytosolic tyrosine kinase, Janus kinase 2 (JAK2) has not been shown in EC. In addition, the role of epigenetic factors including suppressors of cytokine signaling (SOCS) proteins is also unknown for MPN. In this study, the effects of the JAK2V617F mutation on EC and the SOCS 1-4 genes expression and their methylation profiles were investigated. Materials and Methods: The in vitro transduction method of green fluorescent protein (GFP) labeled lentivirus carrying the JAK2 (wild form) or JAK2V617F mutation into human cord vein endothelial cell (HUVEC) was applied. GFP was determined and analyzed with the flow cytometer. Afterwards, the genetically modified EC population was isolated, gating for GFP signal by cell sorter and then DNA and RNA isolations were performed. Gene expressional changes of SOCS1-4 genes were determined in real time RT-PCR and methylation specific PCR was performed with bisulfite modification of DNA. Results: The successful infection of JAK2, JAK2V617F and GFP vectors into EC were achieved. The comparison of the genetically modified EC revealed no morphological differences. A significant increase in the expressions of SOCS1-4 were detected in mutant EH compared to JAK2 and GFP. It was determined that methylation had no effect on suppression of SOCS1-4 expression detected in GFP and JAK2 EC. Conclusion: Future studies will further enlighten the effects of JAK2V617F on EC and its role in thrombotic events. " @default.
• W3097320744 created "2020-11-09" @default.
• W3097320744 creator A5046859388 @default.
• W3097320744 creator A5070486519 @default.
• W3097320744 creator A5080945831 @default.
• W3097320744 date "2020-10-15" @default.
• W3097320744 modified "2023-09-26" @default.
• W3097320744 title "Miyeloproliferatif Neoplazilerde JAK2V617F Mutasyonunun Endotel Hücresine Etkisi ve SOCS1-4 Gen Anlatımlarına Yansıması" @default.
• W3097320744 doi "https://doi.org/10.26650/jarhs2020-790117" @default.
• W3097320744 hasPublicationYear "2020" @default.
• W3097320744 type Work @default.
• W3097320744 sameAs 3097320744 @default.
• W3097320744 citedByCount "0" @default.
• W3097320744 crossrefType "journal-article" @default.
• W3097320744 hasAuthorship W3097320744A5046859388 @default.
• W3097320744 hasAuthorship W3097320744A5070486519 @default.
• W3097320744 hasAuthorship W3097320744A5080945831 @default.
• W3097320744 hasBestOaLocation W30973207441 @default.
• W3097320744 hasConcept C104317684 @default.
• W3097320744 hasConcept C142613039 @default.
• W3097320744 hasConcept C150194340 @default.
• W3097320744 hasConcept C153911025 @default.
• W3097320744 hasConcept C189235521 @default.
• W3097320744 hasConcept C190727270 @default.
• W3097320744 hasConcept C2908647359 @default.
• W3097320744 hasConcept C502942594 @default.
• W3097320744 hasConcept C54355233 @default.
• W3097320744 hasConcept C71924100 @default.
• W3097320744 hasConcept C86803240 @default.
• W3097320744 hasConcept C99454951 @default.
• W3097320744 hasConceptScore W3097320744C104317684 @default.
• W3097320744 hasConceptScore W3097320744C142613039 @default.
• W3097320744 hasConceptScore W3097320744C150194340 @default.
• W3097320744 hasConceptScore W3097320744C153911025 @default.
• W3097320744 hasConceptScore W3097320744C189235521 @default.
• W3097320744 hasConceptScore W3097320744C190727270 @default.
• W3097320744 hasConceptScore W3097320744C2908647359 @default.
• W3097320744 hasConceptScore W3097320744C502942594 @default.
• W3097320744 hasConceptScore W3097320744C54355233 @default.
• W3097320744 hasConceptScore W3097320744C71924100 @default.
• W3097320744 hasConceptScore W3097320744C86803240 @default.
• W3097320744 hasConceptScore W3097320744C99454951 @default.
• W3097320744 hasIssue "3" @default.
• W3097320744 hasLocation W30973207441 @default.
• W3097320744 hasLocation W30973207442 @default.
• W3097320744 hasOpenAccess W3097320744 @default.
• W3097320744 hasPrimaryLocation W30973207441 @default.
• W3097320744 hasRelatedWork W1187839 @default.
• W3097320744 hasRelatedWork W16724221 @default.
• W3097320744 hasRelatedWork W24093694 @default.
• W3097320744 hasRelatedWork W26504633 @default.
• W3097320744 hasRelatedWork W27697048 @default.
• W3097320744 hasRelatedWork W29852207 @default.
• W3097320744 hasRelatedWork W31598443 @default.
• W3097320744 hasRelatedWork W962405 @default.
• W3097320744 hasRelatedWork W11517865 @default.
• W3097320744 hasRelatedWork W30234032 @default.
• W3097320744 hasVolume "3" @default.
• W3097320744 isParatext "false" @default.
• W3097320744 isRetracted "false" @default.
• W3097320744 magId "3097320744" @default.
• W3097320744 workType "article" @default.